Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corticotropin-releasing hormone receptor 2 (CRHR2) is a G protein-coupled receptor that mediates the physiological response to stress by binding corticotropin-releasing hormone (CRH) and related peptides like urocortins. It plays a key role in modulating stress responses, regulating neuroendocrine integration, and controlling feeding behavior and circadian rhythms. Dysregulation of CRHR2 is associated with various conditions including anxiety disorders, cardiovascular diseases, and gastrointestinal disorders. Antagonists targeting this receptor are being explored for therapeutic use.
Antagonism of CRHR2, leading to modulation of stress response and downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-releasing hormone receptor 2 (CRHR2).